A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.

de Jonge AV, van Werkhoven E, Dinmohamed AG, Nijland M, Zwinderman AH, Bossuyt PM, Veldhuis MS, Rutten EGGM, Mous R, Vermaat JSP, Sandberg Y, de Jongh E, Bilgin YM, Boersma R, Koene H, Kersten MJ, de Jong D, Chamuleau MED

Open source

DOI: 10.1038/s41408-023-00854-2
Published: 2023 May 22
Container: Blood cancer journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41408-023-00854-2,
  title = {A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.},
  author = {de Jonge AV and van Werkhoven E and Dinmohamed AG and Nijland M and Zwinderman AH and Bossuyt PM and Veldhuis MS and Rutten EGGM and Mous R and Vermaat JSP and Sandberg Y and de Jongh E and Bilgin YM and Boersma R and Koene H and Kersten MJ and de Jong D and Chamuleau MED},
  year = {2023},
  journal = {Blood cancer journal},
  doi = {10.1038/s41408-023-00854-2},
  url = {https://doi.org/10.1038/s41408-023-00854-2}
}

RIS

TY  - JOUR
TI  - A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
AU  - de Jonge AV
AU  - van Werkhoven E
AU  - Dinmohamed AG
AU  - Nijland M
AU  - Zwinderman AH
AU  - Bossuyt PM
AU  - Veldhuis MS
AU  - Rutten EGGM
AU  - Mous R
AU  - Vermaat JSP
AU  - Sandberg Y
AU  - de Jongh E
AU  - Bilgin YM
AU  - Boersma R
AU  - Koene H
AU  - Kersten MJ
AU  - de Jong D
AU  - Chamuleau MED
PY  - 2023
JO  - Blood cancer journal
DO  - 10.1038/s41408-023-00854-2
UR  - https://doi.org/10.1038/s41408-023-00854-2
ER  -

APA

AV, D. J., E, V. W., AG, D., M, N., AH, Z., PM, B., MS, V., EGGM, R., R, M., JSP, V., Y, S., E, D. J., YM, B., R, B., H, K., MJ, K., D, D. J., & MED, C. (2023). A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.. Blood cancer journal. https://doi.org/10.1038/s41408-023-00854-2

Source records

pubmed · retrieved 2026-09-27T14:17:00.119Z